The Division of Endocrinology, Metabolism & Lipid Research in the Department of Medicine has received a $2.75 million gift through the Anita Palmer Corbin Trust to establish the Anita Palmer Corbin Diabetes Research Endowed Fund. The fund augments a spendable fund to support diabetes research in the division that was previously created by Corbin, who […]
On September 11, 2023, Fumihiko Urano, MD, PhD and Sina Jasim, MD, MPH, were featured on the AACE’s podcast titled “Episode 41: AACE Clinical Case Report on Wolfram Syndrome.” As the editor in chief of AACE Clinical Case Reports, Dr. Jasim welcomes Wolfram syndrome expert Dr. Urano, to discuss his recent case report, published by […]
On August 19, Halis Kaan Akturk, MD of the Barbara Davis Center for Diabetes at University of Colorado and Alexis M. McKee, MD of the Division of Endocrinology, Metabolism and Lipid Research at Washington University School of Medicine, had their review titled “Emerging Technologies and Therapeutics for Type 1 Diabetes,” published online by Science Direct. […]
On May 4, Nathaniel Hogrebe, PhD; Matthew Ishahak, PhD; and Jeffrey Millman, PhD had their review titled “Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes,” published in Cell Stem Cell. In diabetes treatment, there is great potential for islet-like endocrine clusters from human pluripotent stem cells (hPSCs) to provide a limitless […]
On January 1, Janet B. McGill, MD, MA, FACP, and collaborators had their work titled “Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial” published in “Diabetes Technology and Therapeutics.” The focus was “to evaluate safety and effectiveness of MiniMed™ 670G hybrid closed loop (HCL) in comparison […]
In January, Jeffrey Millman, PhD was awarded funding of $450,000 from JDRF for his lab’s project titled “Genetic Engineering to Improve Engraftment of Stem Cell-Derived Islets.” Transplantation of new insulin-producing cells into the patients could be a functional cure for type 1 diabetes. We have developed a method for creating these cells in the lab […]
On November 18, Alexis M. McKee, MD, CDCES had her article titled “What is Automated Insulin Delivery,” published on “EndocrineWeb.” Automated insulin delivery (AID) delivers insulin through a pump that communicates with a continuous glucose monitor (CGM). Also known as a hybrid closed hoop system or an artificial pancreas device system. In the article, McKee […]
On September 28, the National Institutes of Health released information on a pivotal trial for the insulin-only bionic pancreas study. The trial was led by principal investigator, Janet B. McGill, MD, and sub-investigators, Julie M. Silverstein, MD; Maamoun Salam, MD; Samantha Adamson, MD, PhD; and Andrea Cedeno, MD. The bionic pancreas is unique, closed-loop insulin pump, […]